• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

代谢基因 IDH1、IDH2 和 SDHAF2 的突变并非散发性嗜铬细胞瘤和副神经节瘤假性缺氧表型的主要决定因素。

Mutations of the metabolic genes IDH1, IDH2, and SDHAF2 are not major determinants of the pseudohypoxic phenotype of sporadic pheochromocytomas and paragangliomas.

机构信息

Division of Hematology and Molecular Oncology, Department of Medicine and Cellular, Structural Biology, University of Texas Health Science Center, 7703 Floyd Curl Drive, MC7880, San Antonio, Texas 78229, USA.

出版信息

J Clin Endocrinol Metab. 2010 Mar;95(3):1469-72. doi: 10.1210/jc.2009-2245. Epub 2010 Feb 3.

DOI:10.1210/jc.2009-2245
PMID:20130071
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2841540/
Abstract

CONTEXT

Pheochromocytomas and paragangliomas are genetically heterogeneous tumors of neural crest origin. Approximately half of these tumors activate a pseudohypoxic transcription response, which is due in a minority of the cases to germline mutations of the VHL gene or the genes encoding subunits of the metabolic enzyme succinate dehydrogenase (SDH), SDHB, SDHC, or SDHD. However, the genetic basis of the hypoxic-like profile of the remaining tumors is undetermined. Mutations in genes involved in the energy metabolism, isocitrate dehydrogenase 1 (IDH1) and -2 (IDH2) and SDHAF2, a component of SDH, can mimic a pseudohypoxic state.

DESIGN

We examined the sequence spanning the mutation-susceptible codons 132 of IDH1 and 172 of IDH2, and the entire coding region of SDHAF2, in 104 pheochromocytomas and paragangliomas, including tumors with a pseudohypoxic expression profile.

RESULTS

We did not find mutations in IDH1, IDH2, or SDHAF2 in any of the tumors in this cohort.

CONCLUSION

Conserved residues of IDH1 and IDH2 or the SDHAF2 gene are not frequently mutated in pheochromocytomas and paragangliomas. The molecular basis for activation of a hypoxic response in the majority of tumors without VHL or SDH mutations remains to be defined.

摘要

背景

嗜铬细胞瘤和副神经节瘤是起源于神经嵴的具有遗传异质性的肿瘤。这些肿瘤中约有一半会激活假缺氧转录反应,少数情况下是由于 VHL 基因或编码代谢酶琥珀酸脱氢酶(SDH)亚基的基因的种系突变,SDHB、SDHC 或 SDHD。然而,其余肿瘤缺氧样特征的遗传基础尚未确定。参与能量代谢的基因(异柠檬酸脱氢酶 1(IDH1)和 2(IDH2)以及 SDH 的组成部分 SDHAF2)中的突变可以模拟假缺氧状态。

设计

我们检查了 IDH1 的易突变密码子 132 和 IDH2 的 172 以及 SDHAF2 的整个编码区的序列,在 104 例嗜铬细胞瘤和副神经节瘤中,包括具有假缺氧表达谱的肿瘤。

结果

在该队列的任何肿瘤中均未发现 IDH1、IDH2 或 SDHAF2 突变。

结论

IDH1 和 IDH2 或 SDHAF2 基因的保守残基在嗜铬细胞瘤和副神经节瘤中很少发生突变。大多数没有 VHL 或 SDH 突变的肿瘤中激活缺氧反应的分子基础仍有待确定。

相似文献

1
Mutations of the metabolic genes IDH1, IDH2, and SDHAF2 are not major determinants of the pseudohypoxic phenotype of sporadic pheochromocytomas and paragangliomas.代谢基因 IDH1、IDH2 和 SDHAF2 的突变并非散发性嗜铬细胞瘤和副神经节瘤假性缺氧表型的主要决定因素。
J Clin Endocrinol Metab. 2010 Mar;95(3):1469-72. doi: 10.1210/jc.2009-2245. Epub 2010 Feb 3.
2
Isocitrate dehydrogenase mutations are rare in pheochromocytomas and paragangliomas.琥珀酸脱氢酶突变在嗜铬细胞瘤和副神经节瘤中罕见。
J Clin Endocrinol Metab. 2010 Mar;95(3):1274-8. doi: 10.1210/jc.2009-2170. Epub 2009 Nov 13.
3
Genotype and tumor locus determine expression profile of pseudohypoxic pheochromocytomas and paragangliomas.基因型和肿瘤位置决定假性缺氧嗜铬细胞瘤和副神经节瘤的表达谱。
Neoplasia. 2013 Apr;15(4):435-47. doi: 10.1593/neo.122132.
4
SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma.SDHAF2 突变与家族性和散发性副神经节瘤和嗜铬细胞瘤。
Lancet Oncol. 2010 Apr;11(4):366-72. doi: 10.1016/S1470-2045(10)70007-3. Epub 2010 Jan 11.
5
Loss of maternal chromosome 11 is a signature event in SDHAF2, SDHD, and VHL-related paragangliomas, but less significant in SDHB-related paragangliomas.母源11号染色体缺失是SDHAF2、SDHD和VHL相关副神经节瘤的标志性事件,但在SDHB相关副神经节瘤中不太显著。
Oncotarget. 2017 Feb 28;8(9):14525-14536. doi: 10.18632/oncotarget.14649.
6
High prevalence of founder mutations of the succinate dehydrogenase genes in the Netherlands.荷兰琥珀酸脱氢酶基因突变的高发率。
Clin Genet. 2012 Mar;81(3):284-8. doi: 10.1111/j.1399-0004.2011.01653.x. Epub 2011 Mar 15.
7
Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations.与SDHB和SDHD基因突变相关的副神经节瘤综合征的独特临床特征。
JAMA. 2004 Aug 25;292(8):943-51. doi: 10.1001/jama.292.8.943.
8
Transcription association of VHL and SDH mutations link hypoxia and oxidoreductase signals in pheochromocytomas.VHL和SDH突变的转录关联在嗜铬细胞瘤中连接了缺氧和氧化还原酶信号。
Ann N Y Acad Sci. 2006 Aug;1073:208-20. doi: 10.1196/annals.1353.023.
9
Identification of a signaling axis HIF-1α/microRNA-210/ISCU independent of SDH mutation that defines a subgroup of head and neck paragangliomas.鉴定一条不依赖于 SDH 突变的信号轴 HIF-1α/miRNA-210/ISCU,其定义了头颈部副神经节瘤的一个亚组。
J Clin Endocrinol Metab. 2012 Nov;97(11):E2194-200. doi: 10.1210/jc.2012-2410. Epub 2012 Sep 13.
10
Role of SDHAF2 and SDHD in von Hippel-Lindau associated pheochromocytomas.SDHAF2和SDHD在与冯希佩尔-林道病相关的嗜铬细胞瘤中的作用。
World J Surg. 2014 Mar;38(3):724-32. doi: 10.1007/s00268-013-2373-2.

引用本文的文献

1
Non-Susceptibility Gene Variants in Head and Neck Paragangliomas.头颈部副神经节瘤中的非敏感性基因变异
Int J Mol Sci. 2024 Nov 27;25(23):12762. doi: 10.3390/ijms252312762.
2
Tumour microenvironment in pheochromocytoma and paraganglioma.嗜铬细胞瘤和副神经节瘤的肿瘤微环境。
Front Endocrinol (Lausanne). 2023 Mar 22;14:1137456. doi: 10.3389/fendo.2023.1137456. eCollection 2023.
3
The Endothelial Landscape and Its Role in Von Hippel-Lindau Disease.血管内皮景观及其在希佩尔-林道病中的作用。
Cells. 2021 Sep 4;10(9):2313. doi: 10.3390/cells10092313.
4
Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas.《嗜铬细胞瘤和副神经节瘤的诊断、遗传咨询和治疗的多学科实践指南》。
Clin Transl Oncol. 2021 Oct;23(10):1995-2019. doi: 10.1007/s12094-021-02622-9. Epub 2021 May 6.
5
Recent Advances in Histopathological and Molecular Diagnosis in Pheochromocytoma and Paraganglioma: Challenges for Predicting Metastasis in Individual Patients.近期在嗜铬细胞瘤和副神经节瘤的组织病理学和分子诊断方面的进展:预测个体患者转移的挑战。
Front Endocrinol (Lausanne). 2020 Oct 27;11:587769. doi: 10.3389/fendo.2020.587769. eCollection 2020.
6
Molecular evaluation of a sporadic paraganglioma with concurrent IDH1 and ATRX mutations.散发性副神经节瘤中同时存在 IDH1 和 ATRX 突变的分子评估。
Endocrine. 2018 Aug;61(2):216-223. doi: 10.1007/s12020-018-1617-1. Epub 2018 May 30.
7
Light of DNA-alkylating agents in castration-resistant prostate cancer cells: a novel mixed EGFR/DNA targeting combi-molecule.去势抵抗性前列腺癌细胞中DNA烷化剂的曙光:一种新型的EGFR/DNA双重靶向联合分子
Am J Transl Res. 2017 Jul 15;9(7):3245-3257. eCollection 2017.
8
Molecular markers of paragangliomas/pheochromocytomas.副神经节瘤/嗜铬细胞瘤的分子标志物
Oncotarget. 2017 Apr 11;8(15):25756-25782. doi: 10.18632/oncotarget.15201.
9
Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity.嗜铬细胞瘤和副神经节瘤的发病机制:从遗传异质性中学习。
Nat Rev Cancer. 2014 Feb;14(2):108-19. doi: 10.1038/nrc3648. Epub 2014 Jan 20.
10
Role of SDHAF2 and SDHD in von Hippel-Lindau associated pheochromocytomas.SDHAF2和SDHD在与冯希佩尔-林道病相关的嗜铬细胞瘤中的作用。
World J Surg. 2014 Mar;38(3):724-32. doi: 10.1007/s00268-013-2373-2.

本文引用的文献

1
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate.癌症相关的 IDH1 突变会产生 2-羟基戊二酸。
Nature. 2009 Dec 10;462(7274):739-44. doi: 10.1038/nature08617.
2
Isocitrate dehydrogenase mutations are rare in pheochromocytomas and paragangliomas.琥珀酸脱氢酶突变在嗜铬细胞瘤和副神经节瘤中罕见。
J Clin Endocrinol Metab. 2010 Mar;95(3):1274-8. doi: 10.1210/jc.2009-2170. Epub 2009 Nov 13.
3
SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma.SDH5是琥珀酸脱氢酶黄素化所需的基因,在副神经节瘤中发生突变。
Science. 2009 Aug 28;325(5944):1139-42. doi: 10.1126/science.1175689. Epub 2009 Jul 23.
4
Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha.IDH1基因中胶质瘤衍生的突变主要抑制IDH1催化活性并诱导缺氧诱导因子-1α(HIF-1α)。
Science. 2009 Apr 10;324(5924):261-5. doi: 10.1126/science.1170944.
5
IDH1 and IDH2 mutations in gliomas.胶质瘤中的异柠檬酸脱氢酶1(IDH1)和异柠檬酸脱氢酶2(IDH2)突变
N Engl J Med. 2009 Feb 19;360(8):765-73. doi: 10.1056/NEJMoa0808710.
6
IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors.位于第132位残基的异柠檬酸脱氢酶1(IDH1)突变(IDH1(R132))在高级别胶质瘤中频繁出现,但在其他实体瘤中则不然。
Hum Mutat. 2009 Jan;30(1):7-11. doi: 10.1002/humu.20937.
7
An integrated genomic analysis of human glioblastoma multiforme.多形性胶质母细胞瘤的综合基因组分析
Science. 2008 Sep 26;321(5897):1807-12. doi: 10.1126/science.1164382. Epub 2008 Sep 4.
8
Recent advances in the genetics of phaeochromocytoma and functional paraganglioma.嗜铬细胞瘤和功能性副神经节瘤遗传学的最新进展
Clin Exp Pharmacol Physiol. 2008 Apr;35(4):376-9. doi: 10.1111/j.1440-1681.2008.04881.x.
9
Evolving concepts in pheochromocytoma and paraganglioma.嗜铬细胞瘤和副神经节瘤的概念演变
Curr Opin Oncol. 2006 Jan;18(1):1-8. doi: 10.1097/01.cco.0000198017.45982.06.
10
Signalling hypoxia by HIF hydroxylases.HIF羟化酶介导的缺氧信号传导
Biochem Biophys Res Commun. 2005 Dec 9;338(1):617-26. doi: 10.1016/j.bbrc.2005.08.111. Epub 2005 Aug 24.